Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial

Autor: de Bruyn, Guy *, Gordon, David L, Steiner, Theodore, Tambyah, Paul, Cosgrove, Catherine, Martens, Mark, Bassily, Ehab, Chan, Eng-Soon, Patel, Dhaval, Chen, Josh, Torre-Cisneros, Julian, Fernando De Magalhães Francesconi, Carlos, Gesser, Richard, Jeanfreau, Robert, Launay, Odile, Laot, Thelma, Morfin-Otero, Rayo, Oviedo-Orta, Ernesto, Park, Yoon Soo, Piazza, Franco M, Rehm, Christine, Rivas, Enrique, Self, Steve, Gurunathan, Sanjay
Zdroj: In The Lancet Infectious Diseases February 2021 21(2):252-262
Databáze: ScienceDirect